New-onset LBBB following TAVR is associated with increased 1-year mortality, rehospitalization, and permanent pacemaker implantation.
Cardiac resynchronization therapy is a key treatment for patients with HFrEF and electrical dyssynchrony, such as LBBB. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results